BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Other News

Proteo, Stanford University cardiovascular, pulmonary news

Proteo said that in 3Q11 NIH's National Heart, Lung and Blood Institute (NHLBI) awarded the university $10.8 million to study Proteo's Elafin to treat pulmonary arterial hypertension (PAH), ventilator-induced...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >